Efficacy and Safety of Low-Dose Edoxaban by Body Weight in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the Randomized ELDERCARE-AF Trial.
Masaharu AkaoTakeshi YamashitaMasayuki FukuzawaTakuya HayashiKen OkumuraPublished in: Journal of the American Heart Association (2024)
ClinicalTrials.gov. Identifier: NCT02801669.